A detailed history of Lcnb Corp transactions in Novartis Ag stock. As of the latest transaction made, Lcnb Corp holds 9,574 shares of NVS stock, worth $998,376. This represents 0.39% of its overall portfolio holdings.

Number of Shares
9,574
Previous 10,304 7.08%
Holding current value
$998,376
Previous $1.1 Million 0.46%
% of portfolio
0.39%
Previous 0.41%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $77,474 - $88,249
-730 Reduced 7.08%
9,574 $1.1 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $46,747 - $54,221
-505 Reduced 4.67%
10,304 $1.1 Million
Q1 2024

May 10, 2024

SELL
$95.27 - $108.47 $54,780 - $62,370
-575 Reduced 5.05%
10,809 $1.05 Million
Q4 2023

Feb 12, 2024

SELL
$92.27 - $101.54 $16,147 - $17,769
-175 Reduced 1.51%
11,384 $1.15 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $36,471 - $40,475
-385 Reduced 3.22%
11,559 $1.18 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $34,509 - $39,131
373 Added 3.22%
11,944 $1.21 Million
Q1 2023

May 03, 2023

SELL
$80.03 - $92.81 $48,018 - $55,686
-600 Reduced 4.93%
11,571 $1.06 Million
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $18,887 - $23,130
-250 Reduced 2.01%
12,171 $1.1 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $24,248 - $28,359
-325 Reduced 2.55%
12,421 $944,000
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $39,776 - $46,312
-494 Reduced 3.73%
12,746 $1.08 Million
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $102,941 - $116,446
1,285 Added 10.75%
13,240 $1.16 Million
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $2,470 - $2,732
31 Added 0.26%
11,955 $1.05 Million
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $12,185 - $14,175
-149 Reduced 1.23%
11,924 $975,000
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $9,717 - $10,733
-114 Reduced 0.94%
12,073 $1.1 Million
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $31,227 - $37,772
-400 Reduced 3.18%
12,187 $1.15 Million
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $23,984 - $26,572
-292 Reduced 2.27%
12,587 $1.1 Million
Q2 2020

Aug 12, 2020

BUY
$80.93 - $91.1 $28,649 - $32,249
354 Added 2.83%
12,879 $1.13 Million
Q1 2020

May 11, 2020

SELL
$70.67 - $99.01 $5,300 - $7,425
-75 Reduced 0.6%
12,525 $1.03 Million
Q4 2019

Feb 10, 2020

SELL
$84.35 - $95.37 $35,848 - $40,532
-425 Reduced 3.26%
12,600 $1.19 Million
Q3 2019

Nov 08, 2019

BUY
$85.54 - $94.26 $34,900 - $38,458
408 Added 3.23%
13,025 $1.13 Million
Q2 2019

Aug 01, 2019

SELL
$75.4 - $92.8 $161,808 - $199,148
-2,146 Reduced 14.54%
12,617 $1.15 Million
Q1 2019

May 02, 2019

SELL
$75.32 - $86.15 $21,918 - $25,069
-291 Reduced 1.93%
14,763 $1.42 Million
Q3 2018

Nov 09, 2018

SELL
$66.94 - $77.43 $35,478 - $41,037
-530 Reduced 3.4%
15,054 $1.3 Million
Q2 2018

Aug 13, 2018

BUY
$64.91 - $73.36 $123,718 - $139,824
1,906 Added 13.93%
15,584 $1.18 Million
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $17,104 - $20,448
-243 Reduced 1.75%
13,678 $1.11 Million
Q4 2017

Feb 13, 2018

SELL
$72.33 - $77.64 $8,317 - $8,928
-115 Reduced 0.82%
13,921 $1.17 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $1,927 - $2,009
26 Added 0.19%
14,036 $1.21 Million
Q2 2017

Aug 14, 2017

BUY
N/A
14,010
14,010 $1.17 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lcnb Corp Portfolio

Follow Lcnb Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.